Distribution and Clinical Impact of Helicobacter pylori Virulence Factors in Epstein-Barr-Virus-Associated Gastric Cancer
- PMID: 40558170
- PMCID: PMC12189602
- DOI: 10.3390/antibiotics14060580
Distribution and Clinical Impact of Helicobacter pylori Virulence Factors in Epstein-Barr-Virus-Associated Gastric Cancer
Abstract
Background: Helicobacter pylori (HP) and Epstein-Barr virus (EBV) coinfection lead to chronic inflammation and contribute to the development of gastric cancer. However, studies examining the association between HP virulence factors and EBV infection in gastric cancer are limited. This study investigated the polymorphisms of HP virulence factors associated with EBV infection and their effects on clinical outcomes in EBV-associated gastric cancer (EBVaGC). Methods: A total of 96 HP isolates from 54 patients with gastric cancer were divided and analyzed based on EBV coinfection status. Polymerase chain reaction amplifications of virulence factors were conducted using DNA extracts from HP isolates cultured from gastric mucosal specimens. Results: EBV infection was significantly associated with gastric carcinoma with lymphoid stroma morphology and a proximal location in the stomach. Most HP strains from patients with gastric cancer were positive for cagA (100.0%), vacA (100.0%), and iceA1 (87.5%). Among HP isolates with EBV coinfection, the prevalence of iceA2 (21.7% vs. 0.0%, p < 0.001) and ureA (21.7% vs. 4.0%, p = 0.009) was significantly more frequent, and that of iceA1 (78.3% vs. 96.0%, p = 0.009) and vacA s1a (4.3% vs. 22.0%, p = 0.012) was less frequent than those of EBV- colonies. Multivariate analysis indicated that ureA (odds ratio, 6.148; 95% confidence interval [CI], 1.221 to 30.958; p = 0.028) was associated with EBVaGC. No significant difference in clinical outcomes was observed based on the presence of ureA expression in EBVaGC. Conclusions: In gastric cancer, regardless of EBV infection, most HP strains were highly virulent, testing positive for cagA, vacA, and iceA1. Although ureA was significantly associated with EBV infection, it did not influence the clinical outcomes of EBVaGC.
Keywords: Epstein–Barr virus; Helicobacter pylori; stomach neoplasms; virulence factors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Helicobacter pylori and Epstein-Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?Int J Mol Sci. 2023 Apr 30;24(9):8104. doi: 10.3390/ijms24098104. Int J Mol Sci. 2023. PMID: 37175810 Free PMC article.
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2. Cochrane Database Syst Rev. 2016. PMID: 27351542 Free PMC article.
-
Validation of the ABC Method for Gastric Cancer Risk Stratification Across Helicobacter pylori Infections With Diverse CagA Status and Subtypes in Brazil.Cancer Med. 2025 Jul;14(13):e71016. doi: 10.1002/cam4.71016. Cancer Med. 2025. PMID: 40576027 Free PMC article.
-
Long-term survival analysis after radical gastrectomy for Epstein-Barr virus-associated gastric cancer: A multicenter study.Eur J Surg Oncol. 2025 Jun;51(6):109737. doi: 10.1016/j.ejso.2025.109737. Epub 2025 Mar 2. Eur J Surg Oncol. 2025. PMID: 40043593
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous